Advertisement
Advertisement
ICCM
IceCure Medical Ltd. Ordinary Shares
0.24
USDSponsored
0.00
0.00%
May 11, 10:59 UTC -4
Open
ICCM Earnings Reports
Positive Surprise Ratio
ICCM beat 10 of 15 last estimates.
67%
Next Report
In 3 Days
Date of Next Report
May 14, 2026
Estimate for Q1 26 (Revenue/ EPS)
$1.49M
/-$0.04
Implied change from Q4 25 (Revenue/ EPS)
+16.55%
/-42.86%
Implied change from Q1 25 (Revenue/ EPS)
+105.62%
/-33.33%
IceCure Medical Ltd. Ordinary Shares earnings per share and revenue
On Mar 17, 2026, ICCM reported earnings of -0.07 USD per share (EPS) for Q4 25, missing the estimate of -0.04 USD, resulting in a -52.51% surprise. Revenue reached 1.28 million, compared to an expected 1.94 million, with a -34.00% difference. The market reacted with a -5.46% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -0.04 USD, with revenue projected to reach 1.49 million USD, implying an decrease of -42.86% EPS, and increase of 16.55% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
CVS HEALTH CORPORATION
Report Date
May 06, 2026 For Q1 26
Estimate
$2.21
Actual
$2.57
Surprise
+15.80%
Natera, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.54
Actual
-$0.56
Surprise
-2.36%
Viatris Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.51
Actual
$0.59
Surprise
+15.17%
Charles River Laboratories International, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.96
Actual
$2.06
Surprise
+4.98%
Caris Life Sciences, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
$0.00
Surprise
+100.00%
Concentra Group Holdings Parent, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.34
Actual
$0.40
Surprise
+17.03%
Establishment Labs Holdings Inc.
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.35
Actual
-$0.40
Surprise
-12.80%
Progyny, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.30
Actual
$0.50
Surprise
+63.99%
Omada Health, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
$0.01
Surprise
+112.22%
The Oncology Institute, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.02
Surprise
+74.46%
FAQ
What were IceCure Medical Ltd. Ordinary Shares's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, IceCure Medical Ltd. Ordinary Shares reported EPS of -$0.07, missing estimates by -52.51%, and revenue of $1.28M, -34% below expectations.
How did the market react to IceCure Medical Ltd. Ordinary Shares's Q4 2025 earnings?
The stock price moved down -5.46%, changed from $0.71 before the earnings release to $0.67 the day after.
When is IceCure Medical Ltd. Ordinary Shares expected to report next?
The next earning report is scheduled for May 14, 2026.
What are the forecasts for IceCure Medical Ltd. Ordinary Shares's next earnings report?
Based on 4
analysts, IceCure Medical Ltd. Ordinary Shares is expected to report EPS of -$0.04 and revenue of $1.49M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement